Vedana Therapeutics emerged from stealth with a $46M Series A. Led by local biotech veterans, the Seattle startup is developing next-gen, at-home migraine injections. Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
